Vascular surgery

Cardiovascular Systems, Inc. to Attend Three Investor Conferences in August

Retrieved on: 
Tuesday, July 27, 2021
Health, Surgery, Cardiology, Medical devices, Interventional radiology, Atherectomy, Vascular surgery

Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease.

Key Points: 
  • Cardiovascular Systems, Inc., based in St. Paul, Minn., is a medical device company focused on developing and commercializing innovative solutions for treating vascular and coronary disease.
  • The companys orbital atherectomy system treats calcified and fibrotic plaque in arterial vessels throughout the leg and heart and addresses many of the limitations associated with existing surgical, catheter and pharmacological treatment alternatives.
  • For additional information, please visit www.csi360.com and connect on Twitter @csi360.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20210727005130/en/

InspireMD Enrolls and Treats First Patients at Ballad Health System in U.S. Registration C-Guardian Clinical Trial of CGuard EPS

Retrieved on: 
Friday, July 23, 2021
Medical specialties, Medicine, Clinical medicine, Vascular diseases, Neurosurgery, Vascular surgery, Carotid stenting, Interventional radiology, Carotid artery stenosis, Stent, Restenosis, Angioplasty

The first patients, who were under the care of principal investigator, Chris Metzger, M.D., system chair of clinical research at Ballad Health System in Eastern Tennessee, were successfully implanted with the CGuard EPS stent device .

Key Points: 
  • The first patients, who were under the care of principal investigator, Chris Metzger, M.D., system chair of clinical research at Ballad Health System in Eastern Tennessee, were successfully implanted with the CGuard EPS stent device .
  • These are the first of 315 patients who are expected to be enrolled in the trial and treated with CGuard EPS in the treatment of carotid artery stenosis in symptomatic and asymptomatic patients undergoing carotid artery stenting.
  • I believe that the initiation of this trial marks an important milestone for the potential approval of CGuard EPS and the potential of CGuard EPS in advancing the treatment of CAD and stroke prevention, commented Dr. Metzger.
  • The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

Ballad Health hosts first United States clinical trials of CGuard Embolic Protection System

Retrieved on: 
Thursday, July 22, 2021
Medicine, Carotid stenting, Neurosurgery, Vascular surgery, Stroke, Preventive healthcare, Health sciences, Health care

KINGSPORT, Tenn., July 22, 2021 (GLOBE NEWSWIRE) -- Ballad Health is leading a new clinical trial in the United States for a potentially groundbreaking new carotid stent.

Key Points: 
  • KINGSPORT, Tenn., July 22, 2021 (GLOBE NEWSWIRE) -- Ballad Health is leading a new clinical trial in the United States for a potentially groundbreaking new carotid stent.
  • Ballad Health is committed to advancing medical science that has the potential to improve the human condition, said Ballad Health Chairman and Chief Executive Officer Alan Levine.
  • The Appalachian Highlands is leading the United States in bringing what could be the next big breakthrough in stroke prevention.
  • 2 enroller in the United States and globally in at least 30 top research trials, and it is now leading trials for CGuard.

LeMaitre Will Announce Second Quarter 2021 Earnings Results on July 29, 2021

Retrieved on: 
Thursday, July 15, 2021
LeMaitre Vascular, Lemaitre, Lemaitre, Vascular surgery, Musical groups, Musicians, George D. LeMaitre

BURLINGTON, Mass., July 15, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2021 financial results on Thursday, July 29, 2021, after the market close.

Key Points: 
  • BURLINGTON, Mass., July 15, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2021 financial results on Thursday, July 29, 2021, after the market close.
  • The company has scheduled a conference call for 5:00 PM ET the same day to discuss the results, business highlights, and company outlook.
  • The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon.
  • LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.

CryoLife Announces Release Date and Teleconference Call Details for Second Quarter 2021 Financial Results

Retrieved on: 
Thursday, July 15, 2021
Medical specialties, New York Stock Exchange, CryoLife, Aorta, Vascular surgery, Conference call, Branches of biology

ATLANTA, July 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced todaythat second quarter 2021 financial resultswill be released on Thursday, July 29, 2021 after the market closes.

Key Points: 
  • ATLANTA, July 15, 2021 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced todaythat second quarter 2021 financial resultswill be released on Thursday, July 29, 2021 after the market closes.
  • On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m.
  • A replay of the teleconference will be available July 29 through August 5, 2021 and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415.
  • In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investor Relations section of the CryoLife website.

LeMaitre Vascular Announces Proposed Public Offering of Common Stock

Retrieved on: 
Tuesday, July 13, 2021
LeMaitre Vascular, Lemaitre, Vascular surgery

BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced that it has commenced an underwritten public offering of shares of its common stock.

Key Points: 
  • BURLINGTON, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices, implants and services, today announced that it has commenced an underwritten public offering of shares of its common stock.
  • All of the shares to be sold in the offering will be offered by LeMaitre.
  • In addition, LeMaitre intends to grant to the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering, on the same terms and conditions.
  • LeMaitre Vascular develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon.

First Ever Standard Surgical Risk Patient TCAR Data to be Presented at the Society for Vascular Surgery 2021 Vascular Annual Meeting

Medical specialties, Medicine, Surgery, Vascular surgery, Vascular diseases, TCAR, Society for Vascular Surgery, Atherosclerosis, Stroke, Neurosurgery, Carotid stenting

Retrospective data for symptomatic and asymptomatic standard risk patients undergoing CEA and TCAR for atherosclerotic carotid disease was reviewed to show TCAR and CEA have equivalent risk of perioperative stroke, death, or MI and ipsilateral stroke through 1 year.

Key Points: 
  • Retrospective data for symptomatic and asymptomatic standard risk patients undergoing CEA and TCAR for atherosclerotic carotid disease was reviewed to show TCAR and CEA have equivalent risk of perioperative stroke, death, or MI and ipsilateral stroke through 1 year.
  • We are thrilled to have this ground-breaking analysis presented at VAM, the preeminent annual Vascular Surgery conference.
  • In addition to this presentation, Silk Road Medical will be hosting TCAR @ Vascular Live at the Vascular Annual Meeting on Friday, August 20 from 3:05-3:30 p.m. PDT in Exhibit Hall B1.
  • Silk Road Medical will be exhibiting at the Society for Vascular Surgerys Vascular Annual Meeting in booth #401.

Endovascular Aneurysm Repair (EVAR) Market Report 2021: Global Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 & 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
Monday, July 5, 2021
Hospitals, Pharmaceutical, Health, Medical specialties, Angiology, Cardiovascular system, Vascular surgery, Vascular diseases, Interventional radiology, Endovascular aneurysm repair, Evar, Aneurysm, Neurosurgery, Open aortic surgery, Aortic aneurysm

The "Endovascular Aneurysm Repair (EVAR) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Endovascular Aneurysm Repair (EVAR) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • The global endovascular aneurysm repair market exhibited moderate growth during 2015-2020.
  • Looking forward, the global endovascular aneurysm repair market to grow at a CAGR of around 5% during the forecast period (2021-2026).
  • Due to the prevalence of aneurysms, along with the growing geriatric population, endovascular treatment is increasingly being adopted by healthcare providers.

Phlebotomy Career Training Announces their new partnership with Castle Branch

Retrieved on: 
Thursday, July 1, 2021
Phlebotomy, Vascular surgery, Walden University

The partnering of Phlebotomy Career Training and Castle Branch effectively puts the school on the map with other schools such as Michigan State University and Walden University to name a few.

Key Points: 
  • The partnering of Phlebotomy Career Training and Castle Branch effectively puts the school on the map with other schools such as Michigan State University and Walden University to name a few.
  • With Castle Branch on board, students are now able to upload all their documents to a secure repository for a minimal fee.
  • The other great thing is that Castle Branch manages the students information and reaches out to them if they are missing any important documents."
  • According to Phlebotomy Career Training administrators, their affiliation with Castle Branch fills the gaps between clinical rotations and the instructors.

Vivienne J. Halpern, MD is recognized by Continental Who's Who

Retrieved on: 
Wednesday, June 30, 2021
Vascular surgery, Aneurysm

PHOENIX, June 29, 2021 /PRNewswire/ --Vivienne J. Halpern, MD is being recognized by Continental Who's Who as a Top Vascular Surgeon in the field of Medicine for her professional excellence throughout her career and with the Phoenix VA Health Care System.

Key Points: 
  • PHOENIX, June 29, 2021 /PRNewswire/ --Vivienne J. Halpern, MD is being recognized by Continental Who's Who as a Top Vascular Surgeon in the field of Medicine for her professional excellence throughout her career and with the Phoenix VA Health Care System.
  • The highly trained medical team at the Phoenix VA Health Care System demonstrates the highest level of professionalism and integrity.
  • She offers expert vascular surgery services utilizing her skills and interests in limb salvage, wound care, carotid disease, aneurysms, and dialysis.
  • Dr. Halpern dedicates this honorable recognition to Dr. Donna Mendes, Dr. Julie Freshlag, and Dr. Jon Cohen.